Presentation and Management of Cerebral Venous Sinus Thrombosis After Supratentorial Craniotomy.
Journal
Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914
Informations de publication
Date de publication:
11 Jan 2024
11 Jan 2024
Historique:
received:
19
10
2023
accepted:
28
11
2023
medline:
11
1
2024
pubmed:
11
1
2024
entrez:
11
1
2024
Statut:
aheadofprint
Résumé
Cerebral venous sinus thrombosis (CVST) after supratentorial craniotomy is a poorly studied complication, for which there are no management guidelines. This study assessed the incidence, associated risk factors, and management of postoperative CVST after awake craniotomy. This is an observational, retrospective, monocentric analysis of patients who underwent a supratentorial awake craniotomy. Postoperative CVST was defined as a flow defect on the postoperative contrast-enhanced 3D T1-weighted sequence and/or as a T2* hypointensity within the sinus. In 401 supratentorial awake craniotomies (87.3% of diffuse glioma), the incidence of postoperative CVST was 4.0% (95% CI 2.5-6.4): 14/16 thromboses located in the superior sagittal sinus and 12/16 located in the transverse sinus. A venous sinus was exposed during craniotomy in 45.4% of cases, and no intraoperative injury to a cerebral venous sinus was reported. All thromboses were asymptomatic, and only two cases were diagnosed at the time of the first postoperative imaging (0.5%). Postoperative complications, early postoperative Karnofsky Performance Status score, and duration of hospital stay did not significantly differ between patients with and without postoperative CVST. Adjusted independent risk factors of postoperative CVST were female sex (adjusted Odds Ratio 4.00, 95% CI 1.24-12.91, P = .021) and a lesion ≤1 cm to a venous sinus (adjusted Odds Ratio 10.58, 95% CI 2.93-38.20, P < .001). All patients received standard prophylactic-dose anticoagulant therapy, and none received treatment-dose anticoagulant therapy. No thrombosis-related adverse event was reported. All thromboses presented spontaneous sinus recanalization radiologically at a mean of 89 ± 41 days (range, 7-171). CVST after supratentorial awake craniotomy is a rare event with satisfactory clinical outcomes and spontaneous sinus recanalization under conservative management without treatment-dose anticoagulant therapy. These findings are comforting to neurosurgeons confronted with postoperative MRI reports suggesting CVST.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Cerebral venous sinus thrombosis (CVST) after supratentorial craniotomy is a poorly studied complication, for which there are no management guidelines. This study assessed the incidence, associated risk factors, and management of postoperative CVST after awake craniotomy.
METHODS
METHODS
This is an observational, retrospective, monocentric analysis of patients who underwent a supratentorial awake craniotomy. Postoperative CVST was defined as a flow defect on the postoperative contrast-enhanced 3D T1-weighted sequence and/or as a T2* hypointensity within the sinus.
RESULTS
RESULTS
In 401 supratentorial awake craniotomies (87.3% of diffuse glioma), the incidence of postoperative CVST was 4.0% (95% CI 2.5-6.4): 14/16 thromboses located in the superior sagittal sinus and 12/16 located in the transverse sinus. A venous sinus was exposed during craniotomy in 45.4% of cases, and no intraoperative injury to a cerebral venous sinus was reported. All thromboses were asymptomatic, and only two cases were diagnosed at the time of the first postoperative imaging (0.5%). Postoperative complications, early postoperative Karnofsky Performance Status score, and duration of hospital stay did not significantly differ between patients with and without postoperative CVST. Adjusted independent risk factors of postoperative CVST were female sex (adjusted Odds Ratio 4.00, 95% CI 1.24-12.91, P = .021) and a lesion ≤1 cm to a venous sinus (adjusted Odds Ratio 10.58, 95% CI 2.93-38.20, P < .001). All patients received standard prophylactic-dose anticoagulant therapy, and none received treatment-dose anticoagulant therapy. No thrombosis-related adverse event was reported. All thromboses presented spontaneous sinus recanalization radiologically at a mean of 89 ± 41 days (range, 7-171).
CONCLUSION
CONCLUSIONS
CVST after supratentorial awake craniotomy is a rare event with satisfactory clinical outcomes and spontaneous sinus recanalization under conservative management without treatment-dose anticoagulant therapy. These findings are comforting to neurosurgeons confronted with postoperative MRI reports suggesting CVST.
Identifiants
pubmed: 38206001
doi: 10.1227/neu.0000000000002825
pii: 00006123-990000000-01018
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © Congress of Neurological Surgeons 2024. All rights reserved.
Références
Netteland D, Sandset E, Mejlænder-Evjensvold M, et al. Cerebral venous sinus thrombosis in traumatic brain injury: a systematic review of its complications, effect on mortality, diagnostic and therapeutic management, and follow-up. Front Neurol. 2022;13:1079579.
Harris L, Townsend D, Ingleton R, et al. Venous sinus thrombosis in traumatic brain injury: a major trauma centre experience. Acta Neurochir (Wien). 2021;163(9):2615-2622.
Apra C, Kotbi O, Turc G, et al. Presentation and management of lateral sinus thrombosis following posterior fossa surgery. J Neurosurg. 2017;126(1):8-16.
Moore J, Thomas P, Cousins V, et al. Diagnosis and management of dural sinus thrombosis following resection of cerebellopontine angle tumors. J Neurol Surg B Skull Base. 2014;75(6):402-408.
Shabo E, Wach J, Hamed M, et al. Asymptomatic postoperative cerebral venous sinus thrombosis after posterior fossa tumor surgery: incidence, risk factors, and therapeutic options. Neurosurgery. 2023;92(6):1171-1176.
Gessler F, Bruder M, Duetzmann S, et al. Risk factors governing the development of cerebral vein and dural sinus thrombosis after craniotomy in patients with intracranial tumors. J Neurosurg. 2018;128(2):373-379.
Sturiale C, Auricchio A, Valente I. Post-operative segmental cerebral venous sinus thrombosis: risk factors, clinical implications, and therapeutic considerations. Neurosurg Rev. 2023;46(1):161.
Von Elm E, Altman D, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
Pallud J, Rigaux-Viode O, Corns R, et al. Direct electrical bipolar electrostimulation for functional cortical and subcortical cerebral mapping in awake craniotomy. Practical considerations. Neurochirurgie. 2017;63(3):164-174.
Roux A, Dezamis E, Trancart B, et al. How I do it: trans-cortical approach for insular diffuse glioma. Acta Neurochir (Wien). 2020;162(12):3025-3030.
Benjamin C, Sen R, Golfinos J, et al. Postoperative cerebral venous sinus thrombosis in the setting of surgery adjacent to the major dural venous sinuses. J Neurosurg. 2018:1-7.
Gerlach R, Scheuer T, Beck J, et al. Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery. 2003;53(5):1028-1034; discussion 1034-1035.
Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791-1798.
Pallud J, Mandonnet E, Corns R, et al. Technical principles of direct bipolar electrostimulation for cortical and subcortical mapping in awake craniotomy. Neurochirurgie. 2017;63(3):158-163.
Pallud J, Roux A, Trancart B, et al. Surgery of insular diffuse gliomas-part 2: probabilistic cortico-subcortical atlas of critical eloquent brain structures and probabilistic resection map during transcortical awake resection. Neurosurgery. 2021;89(4):579-590.
Elia A, Young J, Simboli G, et al. A preoperative scoring system to predict function-based resection limitation due to insufficient participation during awake surgery. Neurosurgery. 2023;93(3):678-690.
Hervey-Jumper S, Breshears J, Berger M. Gelfoam scaffold for vein prolapse during brain tumor surgery. World Neurosurg. 2014;82(5):912.e11-912.e13.
Shew M, Kavookjian H, Dahlstrom K, et al. Incidence and risk factors for sigmoid venous thrombosis following CPA tumor resection. Otol Neurotol. 2018;39(5):376-380.
de Bruijn S, Stam J, Koopman M, et al. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ. 1998;316(7131):589-592.
Flinn W, Sandager G, Silva M, et al. Prospective surveillance for perioperative venous thrombosis. Experience in 2643 patients. Arch Surg. 1996;131(5):472-480.
Coutinho J. Cerebral venous thrombosis. J Thromb Haemost. 2015;13(suppl 1):S238-S244.
McNeill K. Epidemiology of brain tumors. Neurol Clin. 2016;34(4):981-998.